StemRIM, Shiseido Co., Ltd. and Osaka University Announces Extension of the Tripartite Collaborative Research Agreement Updated on January 24, 2023
November 15, 2023 at 09:00 pm EST
Share
StemRIM Inc. announced that extension the collaborative research period of the tripartite joint research agreement, updated on January 24, 2023, with Shiseido Co. Ltd. and Osaka University. Collaborative research, conducted among company, Shiseido, and Osaka University, focuses on elucidating the aging mechanisms of skin stem cells with a particular emphasis on anti-aging of the skin.
The aim is to create new pharmaceuticals, cosmetics, and related products based on data obtained from understanding the aging mechanisms. Through the ongoing collaborative research, the company have achieved certain research results regarding changes in stem cells related to skin aging. Recognizing the need for further analysis, the company have extended the research period to continue advancing research towards the creation of new pharmaceuticals and cosmetics.
Shiseido Company, Limited specializes in the design, manufacturing and marketing of cosmetics. The group offers beauty products (including makeup items, coloring, etc. ; Shiseido, Aupr's, DQ, Za, Revital Granas, B?n?fique, Maquillage and Elixir), skin care products (skin creams, bath and shower gels, shampoos, etc. ; Aqua Label, Integrate, Tsubaki and Uno), perfumes (Issey Miyake, narciso Rodriguez, Elis Saab and Azzedine Ala?a) as well as professional products (Joico, Decl?or and Carita).
Net sales are distributed geographically as follows: Japan (32.9%), China (25.6%), Asia and Oceania (6.4%), Europe/Middle East/Africa (10.3%), Americas (9.9%) and other (14.9%).